Non-Cross Resistant Sequential Single Agent Chemotherapy in First-Line Advanced Non-Small Cell Lung Cancer Patients: Results of a Phase II Study

por Surmont, V., Aerts, J. G. J. V., Tan, K. Y., Schramel, F., Vernhout, R., Hoogsteden, H. C., van Klaveren, R. J.
Publicado 2009

Optical Detection of Preneoplastic Lesions of the Central Airways

por van der Leest, C., Amelink, A., van Klaveren, R. J., Hoogsteden, H. C., Sterenborg, H. J. C. M., Aerts, J. G. J. V.
Publicado 2012

Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)

por van den Bergh, K A M, Essink-Bot, M L, Borsboom, G J J M, Th Scholten, E, Prokop, M, de Koning, H J, van Klaveren, R J
Publicado 2010

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma

por van Haarst, J M W, Baas, P, Manegold, C h, Schouwink, J H, Burgers, J A, de Bruin, H G, Mooi, W J, van Klaveren, R J, de Jonge, M J A, van Meerbeeck, J P
Publicado 2002